Corporate News Blog - Cerecor Acquired TRx Pharmaceuticals Tue, 21 Nov 2017 12:40:00 +0000 Research Desk Line-up: AscendisPharmaPostEarnings Coverage LONDON, UK / ACCESSWIRE / November 21, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Cerecor ...
Ascendis Pharma A/S Reports Third Quarter 2017 Financial Results Thu, 16 Nov 2017 21:01:00 +0000 -Phase 3 Program for TransCon Growth Hormone Advances and TransCon PTH Enters the Clinic-. -Conference Call Today at 4:30 p.m. Eastern Time-. COPENHAGEN, Denmark, Nov. 16, 2017-- Ascendis Pharma A/S, a ...
Ascendis Pharma A/S Sponsored ADR to Host Earnings Call Thu, 16 Nov 2017 17:00:00 +0000 NEW YORK, NY / ACCESSWIRE / November 16, 2017 / Ascendis Pharma A/S Sponsored ADR (NASDAQ: ASND ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 16, 2017 at ...
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs Wed, 27 Sep 2017 04:16:41 +0000 COPENHAGEN, Denmark, Sept. 27, 2017-- Ascendis Pharma A/S, a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,800,000 American Depositary Shares, ...
Ascendis Pharma A/S Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH Tue, 26 Sep 2017 12:00:00 +0000 COPENHAGEN, Denmark, Sept. 26, 2017-- Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, announced ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.